直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • News
  • Finnegan Facts
  • History
    • Finnegan VISION
    • Finnegan FORWARD
  • Pro Bono
  • Management
    • Pricing & Alternative Fee Arrangements
    • AFA Models We Offer
    • Contingency Fees
    • AI + KM

Commentary

Drop in PTAB Petitions Spurred by Fewer Suits, New Policies

February 26, 2020

Law360

In 2019, the number of new petitions filed at the Patent Trial and Appeal Board (PTAB) was down 23% from the year before. Law360 interviewed Finnegan partner Josh Goldberg for his insight into the decline.

Since U.S. Patent and Trademark Office Director Andrei Iancu took office in early 2018, the PTAB has chosen not to institute review on petitions it views as repetitive, such as when multiple petitions challenging the same patent are filed by the same party or by co-defendants in related litigation. Josh said, “That continued march forward of more and more discretion is, at the margins, causing potential petitioners to either not file at all, or to work together to file a single petition as opposed to multiple petitions.”

Read the full article here.

Related Practices

Patent Office Invalidation Proceedings

Related Offices

Washington, DC

Related Professionals

Joshua L. Goldberg
Partner
Reston, VA
+1 202 408 6092
Email

Related News

Commentary

New Appellate Opinion in Amazon Biometric Data Case May Signal ‘Narrowing’ Scope of BIPA Litigation, Experts Say

May 20, 2026

Award/Ranking

Finnegan Partner Antje Brambrink Shortlisted for Women in Business Law EMEA Award

May 13, 2026

Press Release

Finnegan Secures Decisive ITC Victory for Innoscience in Final Determination

May 11, 2026

Commentary

ITC Bars Import of Innoscience Chips Made Before Redesign

May 8, 2026

Commentary

How Litigation Funding Disclosure Could Affect ITC Cases

May 7 , 2026

Award/Ranking

Associates Rank Finnegan “Best of the Best” in BTI Associate Satisfaction Survey

May 7, 2026

Commentary

Justices to Side with Generic Drugmakers in Patent Spat, Attorneys Predict

May 5, 2026

Announcement

Finnegan Partner Ningling Wang Becomes President of Licensing Executives Society International

May 4, 2026

Commentary

Supreme Court Takes Up Generic Drug Labeling Fight

April 29, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP